BI’s Article search uses Boolean search capabilities. If you are not familiar with these principles, here are some quick tips.

To search specifically for more than one word, put the search term in quotation marks. For example, “workers compensation”. This will limit your search to that combination of words.

To search for a combination of terms, use quotations and the & symbol. For example, “hurricane” & “loss”.

Login Register Subscribe

Workers comp drug formulary bill advances in Pennsylvania House

Workers comp drug formulary bill advances in Pennsylvania House

Pennsylvania lawmakers are considering a workers compensation drug formulary, putting the state in line with a national trend of states governing prescription habits among doctors to curb overprescribing of certain drugs, including opioids. 

The Pennsylvania House of Representatives’ Labor and Industry Committee on Monday received a bill for consideration that would create an evidence-based list of preferred pharmaceuticals in workers comp practices, revising the state’s 102-year-old workers comp code. 

House Bill 18 would mandate the selection of an “evidence-based prescription drug formulary appropriate for resolving issues related to drugs prescribed for or related to the treatment of work-related injuries, including, but not limited to, the type, dosage, and duration of prescriptions,” according to a draft of the bill. 

Drugs or prescription protocols not listed on the formulary would be subject to a “utilization review organization,” according to the draft.



Read Next

  • California closed drug formulary proposal puts spotlight on opioids

    Doctors who wish to repeatedly prescribe opioids to injured workers in California starting July 1 will have to subject the claim to a review process, according to an overview of the proposed workers compensation prescription drug formulary set to go into effect next summer.